Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M189Revenue $M0.3Net Margin (%)-15,828.3Z-Score3.9
Enterprise Value $M76.8EPS $-1.4Operating Margin %-9,198.0F-Score3
P/E(ttm))0Cash Flow Per Share $-0.9Pre-tax Margin (%)-15,828.0Higher ROA y-yN
Price/Book2.110-y EBITDA Growth Rate %-12.9Quick Ratio6.8Cash flow > EarningsY
Price/Sales4445-y EBITDA Growth Rate %9.4Current Ratio6.8Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-114.4Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-445.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M55.8ROI % (ttm)-43.5Gross Margin Increase y-yN

Gurus Latest Trades with CYTR

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CYTRGeorge Soros 2014-03-31 Buy $3.18 - $8.08
($5.96)
$ 3.47-42%New holding, 81800 sh.81,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CYTR is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
CYTR George Soros 2014-03-3181,8000.150New Buy
Premium Most recent portfolio changes are included for Premium Members only!


CYTR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Patterson Scott Bradford10% Owner 2013-12-03Buy284,979$2.4442.21view
Patterson Scott Bradford10% Owner 2013-11-07Buy50,000$2.0668.45view
Patterson Scott Bradford10% Owner 2013-04-01Buy4,083$2.728.52view
Patterson Scott Bradford10% Owner 2013-03-20Buy3,980$2.6132.95view
Patterson Scott Bradford10% Owner 2013-03-20Buy35,520$2.5834.5view
Patterson Scott Bradford10% Owner 2013-03-13Buy55,360$2.6729.96view
Patterson Scott Bradford10% Owner 2012-10-22Buy180,000$2.5138.25view
Patterson Scott Bradford10% Owner 2012-10-18Buy1,200,000$2.538.8view
Patterson Scott Bradford10% Owner 2012-06-28Buy44,824$5.14-32.49view
Patterson Scott Bradford10% Owner 2012-06-25Buy27,462$5-30.6view

Press Releases about CYTR :

    Quarterly/Annual Reports about CYTR:

    News about CYTR:

    Articles On GuruFocus.com
    Weekly CFO Buys Highlight: CYTR, API, CLGX, PLBC, ARTC Mar 05 2012 
    Weekly CEO Buys Highlight: ULBI, BDE, ALNY, CTTR, GFN Feb 27 2012 
    Weekly CFO Buys Highlight: CYTR, PZZI, AGYS, PLBC Feb 27 2012 
    CytRx Corp. Reports Operating Results (10-K) Mar 11 2011 
    CytRx Corp. Reports Operating Results (10-Q) Nov 08 2010 
    CytRx Corp. Reports Operating Results (10-Q) Aug 09 2010 
    CytRx Corp. Reports Operating Results (10-Q) May 06 2010 
    CytRx Corp. Reports Operating Results (10-Q) Nov 09 2009 
    CytRx Reports 2009 Second Quarter Financial Results Aug 10 2009 
    CytRx Corp. Reports Operating Results (10-Q) Aug 07 2009 

    More From Other Websites
    SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into CytRx... Jul 09 2014
    CytRx Added to Russell 3000® and Russell 2000® Indexes Jun 30 2014
    CYTRX CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 27 2014
    Five Analyst Stock Picks With 100% or More Implied Upside Jun 07 2014
    Celldex: The Race Leader In Glioblastoma Multiforme May 29 2014
    CytRx to Present at the Jefferies 2014 Global Healthcare Conference May 29 2014
    CytRx's aldoxorubicin for sarcoma shows positive Phase 2b results May 28 2014
    CytRx Highlights Aldoxorubicin Data from its Global Phase 2b Clinical Trial in First-Line Soft... May 28 2014
    CYTRX CORP Financials May 10 2014
    CYTRX 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and... May 09 2014
    SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against CytRx... May 09 2014
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From... May 08 2014
    Hagens Berman: 7 Days Remain Until May 13, 2014 Lead Plaintiff Deadline in CytRx Securities Fraud... May 06 2014
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against CYTRX CORPORATION... May 06 2014
    INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the... May 06 2014
    CytRx Reports Completed Phase 1b/2 Progression-Free Survival and Overall Survival Aldoxorubicin Data... May 05 2014
    Pre-Market Review on Top Gainers -- Research on SouFun Holdings, CytRx, Iridium Communications, and... May 02 2014
    CYTRX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds... May 01 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide